Intravenous Thrombolysis for Acute Cerebral Ischaemia: Comparison of Outcomes between Patients Treated at Working versus Nonworking Hours

被引:33
作者
Bodenant, Marie [1 ,5 ]
Leys, Didier [1 ,5 ]
Debette, Stephanie [1 ,5 ]
Cordonnier, Charlotte [1 ,5 ]
Dumont, Frederic [1 ,5 ]
Henon, Hilde [1 ,5 ]
Girot, Marie [1 ,3 ,5 ]
Lucas, Christian [1 ,5 ]
Devos, David [1 ]
Defebvre, Luc [1 ]
Deplanque, Dominique [4 ,6 ]
Leclerc, Xavier [2 ,5 ]
Bordet, Regis [4 ,6 ]
机构
[1] Univ Hosp Lille, Dept Neurol, Lille, France
[2] Univ Hosp Lille, Dept Neuroradiol, Lille, France
[3] Univ Hosp Lille, Dept Emergency Med, Lille, France
[4] Univ Hosp Lille, Dept Pharmacol, Lille, France
[5] Univ Lille N, EA 2691, Lille, France
[6] Univ Lille N, EA 1046, Lille, France
关键词
Intravenous thrombolysis; Acute cerebral ischaemia; TISSUE-PLASMINOGEN ACTIVATOR; STROKE PATIENTS; ALTEPLASE; ECASS; GUIDELINES; EXPERIENCE; MORTALITY; TRIAL; UNIT;
D O I
10.1159/000316058
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Stroke outcomes are worse in patients admitted at nonworking hours (NWH), but whether this is also true in patients treated with intravenous (i.v.) thrombolysis has not been definitely proven. Objective: Our aim was to test the hypothesis that stroke patients treated by i.v. rt-PA at NWH have a worse outcome than those treated at working hours (WH). Methods: We compared outcomes at 7 days and at 3 months, between patients treated at NWH and at WH in the stroke unit of the Lille University Hospital. Results: Of 252 consecutive patients [ median age: 69 years; 132 men (52.4%); median National Institutes of Health Stroke Scale score: 14; median onset-to-needle time: 150 min], 134 (53.2%) were treated at NWH. They did not differ for baseline characteristics and proportion of patients with modified Rankin Scale scores 0-1 and 0-2 at 3 months. Patients treated at WH were more likely to die before 7 days (12.7 vs. 4.5%; adjusted odds ratio: 3.6; 95% confidence interval: 1.2-10.4) and at 3 months (21.6 vs. 11.4%; adjusted odds ratio: 2.2; 95% confidence interval: 1.02-4.7). The causes of death did not differ between NWH and WH. At NWH, there was no difference in baseline characteristics and outcomes of patients treated by stroke-and nonstroke neurologists. Conclusion: The case fatality rates were unexpectedly higher at WH than at NWH. If this finding can be reproduced and is not a chance finding, we should identify explanations, especially organisational issues, chronobiological factors or summation of subtle - non-significant -baseline differences. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:148 / 156
页数:9
相关论文
共 27 条
[11]  
Hacke W, 2004, LANCET, V363, P768
[12]   Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [J].
Hacke, Werner ;
Kaste, Markku ;
Bluhmki, Erich ;
Brozman, Miroslav ;
Davalos, Antoni ;
Guidetti, Donata ;
Larrue, Vincent ;
Lees, Kennedy R. ;
Medeghri, Zakaria ;
Machnig, Thomas ;
Schneider, Dietmar ;
von Kummer, Ruediger ;
Wahlgren, Nils ;
Toni, Danilo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1317-1329
[13]   Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 - The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee [J].
Hacke, Werner ;
Ringleb, Peter A. ;
Bousser, Marie-Germaine ;
Ford, Gary ;
Bath, Philip ;
Brainin, Michael ;
Caso, Valeria ;
Cervera, Alvaro ;
Chamorro, Angel ;
Cordonnier, Charlotte ;
Csiba, Laszlo ;
Davalos, Antoni ;
Diener, Hans-Christoph ;
Ferro, Jose ;
Hennerici, Michael ;
Kaste, Markku ;
Langhorne, Peter ;
Lees, Kennedy ;
Leys, Didier ;
Lodder, Jan ;
Markus, Hugh S. ;
Mas, Jean-Louis ;
Mattle, Heinrich P. ;
Muir, Keith ;
Norrving, Bo ;
Obach, Victor ;
Paolucci, Stefano ;
Ringelstein, E. Bernd ;
Schellinger, Peter D. ;
Sivenius, Juhani ;
Skvortsova, Veronika ;
Sunnerhagen, Katharina Stibrant ;
Thomassen, Lars ;
Toni, Danilo ;
von Kummer, Ruediger ;
Wahlgren, Nils Gunnar ;
Walker, Marion F. ;
Wardlaw, Joanna .
CEREBROVASCULAR DISEASES, 2008, 25 (05) :457-507
[14]   Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study [J].
Hill, MD ;
Buchan, AM .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (10) :1307-1312
[15]   Bias in request for medical care and impact on outcome during office and non-office hours in stroke patients [J].
Jauss, M. ;
Oertel, W. ;
Allendoerfer, J. ;
Misselwitz, B. ;
Hamer, H. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (10) :1165-1167
[16]   Quality improvement and tissue-type plasminogen activator for acute ischemic stroke - A Cleveland update [J].
Katzan, IL ;
Hammer, MD ;
Furlan, AJ ;
Hixson, ED ;
Nadzam, DM .
STROKE, 2003, 34 (03) :799-800
[17]   Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience [J].
Katzan, IL ;
Furlan, AJ ;
Lloyd, LE ;
Frank, JI ;
Harper, DL ;
Hinchey, JA ;
Hammel, JP ;
Qu, A ;
Sila, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1151-1158
[18]   Facilities available in European hospitals treating stroke patients [J].
Leys, Didier ;
Ringelstein, E. Bernd ;
Kaste, Markku ;
Hacke, Werner .
STROKE, 2007, 38 (11) :2985-2991
[19]   The main components of stroke unit care: Results of a European expert survey [J].
Leys, Didier ;
Ringelstein, E. Bernd ;
Kaste, Markku ;
Hacke, Werner .
CEREBROVASCULAR DISEASES, 2007, 23 (5-6) :344-352
[20]  
LORENZANO S, 2009, CEREBROVASC DIS S6, V27, P1